Trial Profile
A Phase II Study to Assess the Safety and Efficacy of PTS100 in Primary Hepatocellular Carcinoma Patients Who Are Ineligible for Operation or Current Locoregional Therapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2023
Price :
$35
*
At a glance
- Drugs P-toluenesulfonamide (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms OASES
- Sponsors Gongwin Biopharm
- 28 Mar 2022 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 28 Mar 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2024.
- 03 Feb 2020 Planned End Date changed from 1 Apr 2022 to 1 Dec 2023.